Cargando…

Topically Applied Etamsylate: A New Orphan Drug for HHT-Derived Epistaxis (Antiangiogenesis through FGF Pathway Inhibition)

Hereditary hemorrhagic telangiectasia (HHT) is a vascular dysplasia characterized by recurrent and spontaneous epistaxis (nose bleeds), telangiectases on skin and mucosa, internal organ arteriovenous malformations, and dominant autosomal inheritance. Mutations in Endoglin and ACVRL1 / ALK1 , genes m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albiñana, Virginia, Giménez-Gallego, Guillermo, García-Mato, Angela, Palacios, Patricia, Recio-Poveda, Lucia, Cuesta, Angel-M, Patier, José-Luis, Botella, Luisa-María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660472/ https://www.ncbi.nlm.nih.gov/pubmed/31360828 http://dx.doi.org/10.1055/s-0039-1693710

Ejemplares similares

A Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2
por: Errasti Díaz, Suriel, et al.
Publicado: (2022)

Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds
por: Marcos, Sol, et al.
Publicado: (2021)

Long-term efficacy assessment of current treatment options for epistaxis in HHT
por: Dür, Cilgia, et al.
Publicado: (2021)

Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial
por: Mei-Zahav, Meir, et al.
Publicado: (2020)

Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
por: Lee, John M., et al.
Publicado: (2019)

HHT-Related Epistaxis and Pregnancy—A Retrospective Survey and Recommendations for Management from an Otorhinolaryngology Perspective
por: Andorfer, Kornelia E. C., et al.
Publicado: (2022)

Silicone septal splint for recurrent epistaxis in HHT patients: experience of a national referral centre
por: Matti, Elina, et al.
Publicado: (2023)

Composite Hemostatic Nonwoven Textiles Based on Hyaluronic Acid, Cellulose, and Etamsylate
por: Suchý, Pavel, et al.
Publicado: (2020)

Blockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma
por: Albiñana, Virginia, et al.
Publicado: (2022)

The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases
por: Cuesta, Angel M., et al.
Publicado: (2022)

Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
por: Albiñana, Virginia, et al.
Publicado: (2022)

Evaluation of the effect of etamsylate on thromboelastographic traces of canine blood with and without the addition of heparin
por: Herrería-Bustillo, Vicente, et al.
Publicado: (2023)

CLN5 in heterozygosis may protect against the development of tumors in a VHL patient
por: de Rojas-P, Isabel, et al.
Publicado: (2020)

Hydrogel-based matrices for controlled drug delivery of etamsylate: Prediction of in-vivo plasma profiles
por: El-Masry, Soha M., et al.
Publicado: (2020)

Research on potential biomarkers in hereditary hemorrhagic telangiectasia
por: Botella, Luisa-María, et al.
Publicado: (2015)

Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding
por: Albiñana, Virginia, et al.
Publicado: (2020)

Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)
por: Zarrabeitia, Roberto, et al.
Publicado: (2017)

The Endothelial Landscape and Its Role in Von Hippel–Lindau Disease
por: de Rojas-P, Isabel, et al.
Publicado: (2021)

Current HHT genetic overview in Spain and its phenotypic correlation: data from RiHHTa registry
por: Sánchez-Martínez, Rosario, et al.
Publicado: (2020)

Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence
por: de Gussem, Els M., et al.
Publicado: (2020)

TIMolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (TIM-HHT)—A Prospective, Randomized, Double-Blind, Controlled, Cross-Over Trial
por: Andorfer, Kornelia E. C., et al.
Publicado: (2022)

Mononuclear cells and vascular repair in HHT
por: Dingenouts, Calinda K. E., et al.
Publicado: (2015)

Genotype–Phenotype Correlations in Children with HHT
por: Kilian, Alexandra, et al.
Publicado: (2020)

Monitoring antiangiogenesis of bevacizumab in zebrafish
por: Zhang, Jing, et al.
Publicado: (2018)

SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population
por: Marcos, Sol, et al.
Publicado: (2021)

Data on the hemostasis in epistaxis with Topically Administered TXA Versus Topical Oxymetazoline Spray
por: Whitworth, Kristen, et al.
Publicado: (2020)

Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1
por: Albiñana, Virginia, et al.
Publicado: (2017)

Surrogate markers in antiangiogenesis clinical trials
por: Davis, D W, et al.
Publicado: (2003)

Antiangiogenesis in recurrent glioblastoma: proof of principle
por: Nossek, Erez, et al.
Publicado: (2009)

Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
por: Wan, Xueting, et al.
Publicado: (2021)

Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial
por: González-Rodríguez, Beatriz, et al.
Publicado: (2019)

Epistaxis
por: Díaz Reyes, Abigail
Publicado: (2010)

Epistaxis
Publicado: (1909)

Epistaxis
por: Barton, B. W.
Publicado: (1878)

Epistaxis
por: de Mello, João Ferreira
Publicado: (2015)

Time heals all wounds—but 12-HHT is faster
por: Gus-Brautbar, Yael, et al.
Publicado: (2014)

Classification of endonasal HHT lesions using digital microscopy
por: Haubner, F., et al.
Publicado: (2021)

Incidence of Spontaneous Pulmonary AVM Rupture in HHT Patients
por: Fish, Adam, et al.
Publicado: (2021)

Improved HHT-microstate analysis of EEG in nicotine addicts
por: Xiong, Xin, et al.
Publicado: (2023)

A case report of hepatopulmonary syndrome in hereditary hemorrhagic telangiectasia (HHT): Not all right-to-left shunting in HHT is due to pulmonary arteriovenous malformations
por: Krishnan, Sheila, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sbbor6obb9cv5quc35sort6u14